Alnylam Pharmaceuticals, Inc.

Ticker

ALNY

ISIN

US02043Q107

Price

USD 150.85

Change Today

+1.23 / 0.819 %

Price 1 year ago

189.87 / -20.554 %

Market Capitalization

25,228,636,160.00

52 Week Low

143.31

52 Week High

211.65

200 Day Moving Average

168.58

50-day Moving Average

149.36


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Country

United States

Exchange

NMS

Earnings Per Share

-7.55

P/E Ratio

-

Debt/Equity Ratio

562.926

Beta

0.798637

City

Cambridge

Address

675 West Kendall Street

Zip

02142

Ebitda

-671,937,984.00

Ebitda Margins

-0.76

Enterprise to Ebitda

-49.08

Enterprise Value

32,977,506,304.00

Target Price

205.76

Estimated Price

-

Book Value

7.89

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
TMBR Timber Pharmaceuticals, Inc. -0.59
ATHX Athersys, Inc. -0.54
DNA Ginkgo Bioworks Holdings, Inc. -0.51
300147.SZ XIANGXUE PHARMACEU -0.45
002007.SZ HUALAN BIOLOGICAL -0.39
600201.SS JINYU BIO-TECHNOLOGY CO LTD -0.34
300122.SZ CHONGQING ZHIFEI B -0.31
1177.HK SINO BIOPHARM -0.29
0775.HK CKLIFE SCIENCES -0.19
BLUE bluebird bio, Inc. -0.17
002252.SZ S/H RAAS BLOOD PRO -0.15
1873.HK VIVA BIOTECH -0.11
300363.SZ PORTON PHARMA SOLU -0.11
1801.HK INNOVENT BIO -0.07
ALPHA.PA PHARNEXT -0.06
AKBA Akebia Therapeutics, Inc. -0.05
2269.HK WUXI BIO -0.02
300497.SZ JIANGXI FUSHINE PH 0.01
1530.HK 3SBIO 0.05
300009.SZ ANHUI ANKE BIOTECH 0.14
2137.HK BRII-B 0.18
300204.SZ STAIDSON (BEIJING) 0.21
2370.T MEDINET CO LTD 0.22
TRX.L TISSUE REGENIX GROUP PLC 0.23
600866.SS STAR LAKE BIOSCIENCE CO INC Z 0.29
600200.SS JIANGSU WUZHONG PHARMACEUTICAL 0.37
IMU.AX IMUGENE FPO 0.58
300181.SZ ZHEJIANG JOLLY PHA 0.60

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
ALPHA.PA PHARNEXT Issy-les-Moulineaux France EUR PAR 2.86 -0.65 40 https://www.pharnext.com
1177.HK SINO BIOPHARM Wan Chai Hong Kong HKD HKG 0.48 17.58 25579 https://www.sinobiopharm.com
0775.HK CKLIFE SCIENCES Tai Po Hong Kong HKD HKG 0.40 32.46 1855 https://www.ck-lifesciences.com
DNA Ginkgo Bioworks Holdings, Inc. Boston United States USD NYQ -1.24 641 https://www.ginkgobioworks.com
002252.SZ S/H RAAS BLOOD PRO Shanghai China CNY SHZ 0.21 19.62 2966 https://www.raas-corp.com
002007.SZ HUALAN BIOLOGICAL Xinxiang China CNY SHZ 0.03 19.25 2927 https://www.hualanbio.com
600200.SS JIANGSU WUZHONG PHARMACEUTICAL Suzhou China CNY SHH 0.56 -710.43 https://www.600200.com
600866.SS STAR LAKE BIOSCIENCE CO INC Z Zhaoqing China CNY SHH 0.35 21.35 2608 https://www.starlake.com.cn
TRX.L TISSUE REGENIX GROUP PLC Garforth United Kingdom GBp LSE 1.40 -10.94 79 https://www.tissueregenix.com
2269.HK WUXI BIO Wuxi China HKD HKG 0.91 85.17 9864 https://www.wuxibiologics.com
IMU.AX IMUGENE FPO Sydney Australia AUD ASX 2.28 -30.30 https://www.imugene.com
600201.SS JINYU BIO-TECHNOLOGY CO LTD Hohhot China CNY SHH 0.31 18.76 1580 https://www.jinyu.com.cn
TMBR Timber Pharmaceuticals, Inc. Basking Ridge United States USD ASE 0.19 5 https://www.timberpharma.com
300181.SZ ZHEJIANG JOLLY PHA Huzhou China CNY SHZ 0.10 18.50 2132 https://www.zuoli.com
CLVS Clovis Oncology, Inc. Boulder United States USD NMS 0.49 -3.78 413 https://www.clovisoncology.com
ATHX Athersys, Inc. Cleveland United States USD NCM -1.30 -0.60 104 https://www.athersys.com
VTGN VistaGen Therapeutics, Inc. South San Francisco United States USD NCM 1.06 0.75 36 https://www.vistagen.com
300009.SZ ANHUI ANKE BIOTECH Hefei China CNY SHZ 0.38 19.32 https://www.ankebio.com
300122.SZ CHONGQING ZHIFEI B Chongqing China CNY SHZ 0.77 11.89 4800 https://www.zhifeishengwu.com
2370.T MEDINET CO LTD Tokyo Japan JPY JPX 1.34 -2.69 92 https://www.medinet-inc.co.jp
2137.HK BRII-B Beijing China HKD HKG -5.41 113 https://www.briibio.com
1530.HK 3SBIO Shenyang China HKD HKG 0.84 6.75 5292 https://www.3sbio.com
1801.HK INNOVENT BIO Suzhou China HKD HKG -0.31 -14.04 5568 https://www.innoventbio.com
300497.SZ JIANGXI FUSHINE PH Jingdezhen China CNY SHZ 0.14 35.19 1849 https://www.fushine.cn
300147.SZ XIANGXUE PHARMACEU Guangzhou China CNY SHZ 0.59 374.63 3378 https://www.xphcn.com
BLUE bluebird bio, Inc. Cambridge United States USD NMS 1.38 -0.35 518 https://www.bluebirdbio.com
300204.SZ STAIDSON (BEIJING) Beijing China CNY SHZ 0.16 -27.06 873 https://www.staidson.com
AKBA Akebia Therapeutics, Inc. Cambridge United States USD NGM 1.47 -0.16 426 https://www.akebia.com
1873.HK VIVA BIOTECH Shanghai China HKD HKG 0.95 15.94 2127 https://www.vivabiotech.com.cn
300363.SZ PORTON PHARMA SOLU Chongqing China CNY SHZ -0.36 30.90 4158 https://www.porton.cn
VLON Vallon Pharmaceuticals Inc. Philadelphia United States USD NCM -1.15 -0.24 2 https://www.vallon-pharma.com
SRNE Sorrento Therapeutics, Inc. San Diego United States USD NCM 2.17 -2.59 799 https://www.sorrentotherapeutics.com
NVAX Novavax, Inc. Gaithersburg United States USD NMS 1.58 -2.58 1541 https://www.novavax.com
300759.SZ PHARMARON BEIJING Beijing China CNY SHZ 0.28 49.23 14923 https://www.pharmaron.com
300404.SZ BOJI MEDICAL & TEC Guangzhou China CNY SHZ -0.10 63.41 989 https://www.bojicro.com
RIGL Rigel Pharmaceuticals, Inc. South San Francisco United States USD NMS 1.66 -2.33 165 https://www.rigel.com
688180.SS SHANGHAI JUNSHI BIOSCIENCES CO Shanghai China CNY SHH 0.24 -39.92 2805 https://www.junshipharma.com
600161.SS BEIJING TIANTAN BIOLOGICAL PROD Beijing China CNY SHH 0.02 23.29 3933 https://www.tiantanbio.com
9939.HK KINTOR PHARMA-B Suzhou China HKD HKG -0.77 -5.99 316 https://www.kintor.com.cn
VERU Veru Inc. Miami United States USD NCM -0.41 -41.18 252 https://www.verupharma.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.